News & Updates

In patients hospitalized for severe COVID-19, adding the plant flavonoid quercetin to the antiviral drugs remdesivir or favipiravir reduced hospitalization period and levels of inflammatory markers related to the pathogenesis of SARS-CoV-2, thus preventing the progression of the disease into its critical phase, suggests an open-label study from Iran.

While the strict and rapid implementation of border restrictions, contact tracing, case isolation, social-distancing, and quarantine protocols can effectively suppress COVID-19 transmission, densely populated environments, as in the case of migrant worker dormitories in Singapore, remain at risk of outbreaks, according to a recent study.

A registry-based study has recently shown diverse COVID-19 vaccine-associated dermatologic reactions, including papulovesicular, pityriasis rosea-like, and papulosquamous eruptions classified as vaccine-related eruption of papules and plaques (V-REPP).

Treatment with tirzepatide leads to a reduction in body weight and improvement in glycaemic control in individuals with type 2 diabetes (T2D), reports a study. In addition, it modulates metabolites associated with T2D risk and metabolic dysregulation that is consistent with improved metabolic health.

Women appear to be at higher risk of colorectal cancer death following adenoma removal, whereas men are at lower risk, as reported in a recent study.